Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) Shorted Shares Strengthened By 76.28%

It was noted an increase on Sonoma Pharmaceuticals Inc (NASDAQ:SNOA)’s shorted shares with 76.28%. FINRA published in January SNOA’s total 509,800 shorted shares. That’s 76.28% up from 289,200 shares. With Average volume 587,600, SNOA’s previous position will take 1 days to recover.

Ticker’s shares touched $0.74 during the last trading session after 3.21% change.Sonoma Pharmaceuticals, Inc. has volume of 135,287 shares. Since January 11, 2018 SNOA has declined 83.30% and is downtrending. SNOA underperformed the S&P500 by 83.30%.

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in the United States, Latin America, Europe, and internationally.The firm is valued at $4.88 million. The firm offers Microcyn line of products that are based on electrically charged oxychlorine small molecules designed to target a range of pathogens, such as viruses, fungi, and spores, as well as bacteria, including antibiotic-resistant strains.Currently it has negative earnings. The Company’s products also include Celacyn, a prescription hypochlorous acid based scar management gel; Ceramax Skin Barrier Cream to manage dry itchy skin, minor skin irritations, rashes, and inflammation; Mondoxyne, a prescription oral tetracycline antibiotic for the treatment of various bacterial infections; Alevicyn, a prescription hypochlorous acid based atopic dermatitis product line to reduce itch and pain associated with various dermatoses; and SebuDerm, a prescription topical gel for the management of burning, itching, and scaling in seborrhea and seborrheic dermatitis.

For more Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) news brought out briefly go to:,,, or The titles are as follows: “Sonoma Pharmaceuticals | $SNOA Stock | Shares Jump 30% After FDA Approval – Warrior Trading News” brought out on April 05, 2018, “Sonoma Pharma up 21% – Seeking Alpha” on October 04, 2018, “Earnings Estimates Going Higher – Nasdaq” with a publish date: February 02, 2018, “Sonoma Pharmaceuticals, Inc. 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” and the last “Sonoma Pharmaceuticals, Inc. 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” with publication date: June 13, 2018.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.